Lobbying Filing Details

Total Spending

$680,000

Activities

5

Lobbyists

4

Gov't Entities

30

Filing Information
Filing UUID:
28535266-e3b3-45b6-a557-6f17ea2e7f0e
Type:
Q3 - 3rd Quarter - Report
Period:
2019 - 3rd Quarter (July 1 - Sep 30)
Date Posted:
October 21, 2019 at 7:00 PM
Income:
$0
Expenses:
$680,000
Expense Method:
Method A - Reporting amounts using LDA definitions only
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Elizabeth Hall
Registrant
ELEVANCE HEALTH, INC.

Health Benefits Company

Washington, District of Columbia
Client
ELEVANCE HEALTH, INC.
District of Columbia, United States of America
Lobbying Activities (5)
Activity 1
Health Issues

ACA implementation (exchange operations and functionality, risk mitigation programs, risk adjustment)
ACA reform (reconciliation, individual mandate, cost sharing reduction subsidies, reinsurance transitional policies)
Individual market and exchange stabilization
Prior authorization
Hospital Consolidation
Privacy and Healthcare Cybersecurity
Social Determinants of Health (SDOH)
Association health plans
Mental health and substance use,42 CFR Part 2, Parity and compliance issues
Surprise medical billing; Lower Health Care Cost Act of 2019 (S. 1895), and No Surprises Act (H.R. 3630)
Price of prescription drugs
Medical Loss Ratios
Commercial Risk adjustment data validation (RADV)
Senate HELP Committee Lower Health Care Costs Act
Senate Finance Committee Prescription Drug Pricing Reduction Act; HR 3
Pharmacy Benefit Manager (PBM) operations and practices, Spread pricing, Lower Health Care Cost Act of 2019 (S. 1895)

Lobbyists (4)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
Government Entities (6)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Office of Management & Budget (OMB)
  • Health & Human Services, Dept of (HHS)
  • ... and 1 more
Activity 2
Insurance

ACA implementation (exchange operations and functionality, risk mitigation programs, risk adjustment)
ACA reform (reconciliation, individual mandate, cost sharing reduction subsidies, reinsurance transitional policies)
Individual market and exchange stabilization
Prior authorization
Hospital Consolidation
Privacy and Healthcare Cybersecurity
Social Determinants of Health (SDOH)
Association health plans
Mental health and substance use,42 CFR Part 2, Parity and compliance issues
Surprise medical billing; Lower Health Care Cost Act of 2019 (S. 1895), and No Surprises Act (H.R. 3630)
Price of prescription drugs
Medical Loss Ratios
Commercial Risk adjustment data validation (RADV)
Senate HELP Committee Lower Health Care Costs Act
Senate Finance Committee Prescription Drug Pricing Reduction Act; HR 3
Pharmacy Benefit Manager (PBM) operations and practices, Spread pricing, Lower Health Care Cost Act of 2019 (S. 1895)

Lobbyists (4)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
Government Entities (6)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Office of Management & Budget (OMB)
  • Health & Human Services, Dept of (HHS)
  • ... and 1 more
Activity 3
Medicare/Medicaid

Medicare Advantage (risk adjustment, coding intensity, encounter data, dual-eligible members,
reauthorization of special need plans, star ratings, normalization factors, stars contract
consolidation)
Medicare RAD-V
Mental health and substance use (42 CFR Part 2)
Medicaid managed care
Medicaid expansion
Medicaid reform (block grants, per capita caps)
Medicaid and CHIP reauthorization
Medicaid actuarial soundness
Long-term services and supports
Social Determents of Health (SDOH)
Medicare Part D prescription drug program and Medicare Part D coverage gap (donut hole)
Removal of safe harbor protections for rebates involving prescription drugs and the creation of
new safe harbor protection for certain point-of-sale reductions on price on prescription drugs and
certain Pharmacy Benefit Manager (PBM) service fees
Medicare Part D crosswalk policy
Opioid addiction issues and response (prescription drug monitoring programs)
Medicaid medical loss ratio remittance
Medicaid non-emergency medical transportation
Medicare Advantage Pilot Program in TRICARE

Lobbyists (4)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
Government Entities (6)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Office of Management & Budget (OMB)
  • Health & Human Services, Dept of (HHS)
  • ... and 1 more
Activity 4
Pharmacy

Senate HELP Committee Lower Health Care Costs Act
Senate Finance Committee Prescription Drug Pricing Reduction Act; HR 3
Price of prescription drugs

Lobbyists (4)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
Government Entities (6)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Office of Management & Budget (OMB)
  • Health & Human Services, Dept of (HHS)
  • ... and 1 more
Activity 5
Taxation/Internal Revenue Code

To extend the moratorium and/or repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act
Health Insurance Tax Relief Act of 2019 (H.R. 1398)
Jobs and Premium Protection Act (H.R. 2447)
Jobs and Premium Protection Act (S. 80)
Health Insurance Tax Relief Act of 2019 (S.172)
Tax exclusion for employer-sponsored health insurance

Lobbyists (4)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
Government Entities (6)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Office of Management & Budget (OMB)
  • Health & Human Services, Dept of (HHS)
  • ... and 1 more

Source: LDA.gov, data retrieved November 10, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.